- The unexpected intersection between art and science
It’s a common misconception that art and science are vastly different; that they never overlap. But creativity is as essential to the scientific process as it is to the artistic method. Artists and scientists share a curiosity for the unknown, an appreciation for the beauty of the worlds they explore and an interest in creating something new.
January 19, 2017 10:30 AMdetail
- With $3.2 million grant from NIH, UCLA researcher to optimize selection of lung cancer patients for immunotherapy
Dr. Edward Garon, UCLA Jonsson Comprehensive Cancer Center member and associate professor of hematology and oncology at the David Geffen School of Medicine, has received a five-year, $3.2 million grant from the National Institutes of Health to advance the understanding of which people with non-small cell lung cancer respond to immunotherapy.
January 17, 2017 9:30 AMdetail
- UCLA-led study provides roadmap to more personalized cancer treatment
Researchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation.
December 22, 2016 8:00 AMdetail
- Chinese herbal treatment shows signs of effectiveness in bone marrow recovery
Researchers have found that a Chinese herbal regimen called TSY-1 (Tianshengyuan-1) TSY-1 increased telomerase activity in normal blood cells but decreased it in cancer cells. These results indicate that telomerase-based treatments may be of significance in treatments for both blood cell deficiency and cancer.
December 14, 2016 2:00 PMdetail
- ‘Turbocharged artificial intelligence’ could personalize combination therapy in pediatric leukemia
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.
December 12, 2016 9:00 AMdetail
- UCLA researchers uncover new evidence linking inflammation and increased prostate cancer risk
Results of a new UCLA study suggest that inflammation increases overall risk for prostate cancer by increasing the available pool of progenitor cells that can develop into the disease
December 06, 2016 9:00 AMdetail
- Genetic factors control regenerative properties of blood-forming stem cells, UCLA studies show
UCLA researchers have published two studies that define how key genetic factors affect blood-forming stem cells by either accelerating or hindering the cells’ regenerative properties. The findings could one day lead to improved treatments for people undergoing common therapies for cancer such as chemotherapy and radiation.
December 05, 2016 12:00 PMdetail
- Drug combination therapy for estrogen-receptor-positive breast cancer passes critical step for worldwide approval
Building on earlier clinical trials, UCLA researchers have confirmed that the "breakthrough" drug palbociclib when used in combination with the traditional hormonal therapy letrozole delays progression of advanced breast cancer significantly and without the harsh side effects seen in some women prescribed letrozole alone.
November 16, 2016 2:00 PMdetail
- In memoriam: Kim Irwin
Kimberly "Kim" Dawn Irwin, a longtime member of the media and a loving daughter, sibling and aunt, died Oct. 7 following a brief illness. She was 55.
November 07, 2016 12:30 PMdetail
- Breakthrough drug extensively evaluated by UCLA scientist approved as alternative to chemotherapy for people with advanced lung cancer
Pembrolizumab, an immunotherapy drug that was extensively evaluated by UCLA cancer researcher Dr. Edward Garon, has been approved by the U.S. Food & Drug Administration as first-line treatment for advanced lung cancer, giving more patients access to the drug without first having to receive chemotherapy.
October 24, 2016 3:30 PMdetail